Immune system: our new fingerprint

In recent years, a considerable number of melanoma patients have shown great tumour regression when treated with immunotherapy agents. However, there is still a long way to go, when it comes to effectively select the patients that will actually benefit from these. My PhD project at Lund University, focusesRead More

Popular Science: A bridge linking us to the outer world

Scientists are known to be hard working professionals, but if we ask a lawyer or a teacher what we do exactly, most likely they will not be able to answer. The presence of scientific news is frequent in our daily lives, and still we live in a time whenRead More

Outreaching epigenetics in melanoma at University of Helsinki

It was a great pleasure for me to represent MELGEN ESRs at the in Helsinki this year. This is an organized series arranged by the Institute for Molecular Medicine Finland (FIMM) and the Centre for Genomic Regulation (CRG’s joint EU-LIFE) to bridge clinical and basic/translational research. It also aims to provide examples of howRead More

Can we trick melanoma? Unveiling novel solutions to relapse.

Cancer is a heterogeneous disease. However, it has some common features across the different existing types. One of those is relapse. Relapse is defined as “to fall back into the state of illness after apparent recovery”. Every day, researchers are trying to understand why and how cancer returns, andRead More